DTMT Network
Pfizer’s under development SARS-CoV-2 protease inhibitor antiviral therapy for oral use has the potential of reducing hospitalisation or death by as much as 89% in COV
As this issue of your newspaper reaches you, the second wave of the coronavirus pandemic is upon us in India. The second wave started close on the heels of the first one petering o
Rohit Shishodia
India’s health ministry had entrusted the work to carry out a survey to probe the extent of problems of ‘spurious and not of standard quality drug
